Ectopic expression of a small cell lung cancer transcription factor, INSM1 impairs alveologenesis in lung development
暂无分享,去创建一个
[1] T. Jacks,et al. The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[2] A. McKenna,et al. Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing , 2014, Cell.
[3] Nicholas T. Ingolia,et al. PTEN Is a Potent Suppressor of Small Cell Lung Cancer , 2014, Molecular Cancer Research.
[4] V. Londhe,et al. A subset of epithelial cells with CCSP promoter activity participates in alveolar development. , 2011, American journal of respiratory cell and molecular biology.
[5] A. Sweet-Cordero,et al. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. , 2010, Cancer research.
[6] M. Breslin,et al. Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] M. Breslin,et al. Zinc Finger Transcription Factor INSM1 Interrupts Cyclin D1 and CDK4 Binding and Induces Cell Cycle Arrest* , 2009, Journal of Biological Chemistry.
[8] C. Birchmeier,et al. Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage , 2008, Development.
[9] C. Galambos,et al. Regulation of alveologenesis: clinical implications of impaired growth , 2008, Pathology.
[10] B. Hogan,et al. Lung development and repair: Contribution of the ciliated lineage , 2007, Proceedings of the National Academy of Sciences.
[11] D. Ravi,et al. Altered expression of cyclins and cdks in premature infant baboon model of bronchopulmonary dysplasia. , 2004, Antioxidants & redox signaling.
[12] A. Berns,et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. , 2003, Cancer cell.
[13] Cesar M. Castro,et al. Attenuation of Pulmonary Neuroendocrine Differentiation in Mice Lacking Clara Cell Secretory Protein , 2000, Laboratory Investigation.
[14] B. Stripp,et al. Conditional clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[15] F. DeMayo,et al. MORPHOMETRIC ANALYSIS OF CC10-hASH1 TRANSGENIC MOUSE LUNG: A Model for Bronchiolization of Alveoli and Neuroendocrine Carcinoma , 2000, Experimental lung research.
[16] A. Jobe. The New BPD: An Arrest of Lung Development , 1999, Pediatric Research.
[17] M. Lan,et al. Genomic organization, 5'-upstream sequence, and chromosomal localization of an insulinoma-associated intronless gene, IA-1. , 1994, The Journal of biological chemistry.
[18] M. Lan,et al. IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. , 1993, Cancer research.
[19] J. Gitlin,et al. Cell-specific expression of a Clara cell secretory protein-human growth hormone gene in the bronchiolar epithelium of transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. de Silva,et al. A novel human insulinoma-associated cDNA, IA-1, encodes a protein with "zinc-finger" DNA-binding motifs. , 1992, The Journal of biological chemistry.
[21] R. Holle,et al. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. , 1991, British Journal of Cancer.
[22] B. Stripp,et al. Alteration of pulmonary neuroendocrine cells during epithelial repair of naphthalene-induced airway injury. , 2000, The American journal of pathology.
[23] A. A. ten Have-Opbroek,et al. Lung development in the mouse embryo. , 1991, Experimental lung research.
[24] A. A. W. Have-Opbroek,et al. Lung development in the mouse embryo. , 1991 .